Source: Annual Congress 2003 - Mechanisms of epithelial cell activation I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Alberto, G. Laura, G. Cinzia, R. Annamaria, B. Fulvio, C. G. Walter (Genoa, Italy). SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role. Eur Respir J 2003; 22: Suppl. 45, 581

Member's Comments

No comment yet.

Related content which might interest you: The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 The role of serum IL6 in stable COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study. Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017 The prognostic role of the bronchiectasis in patients with COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016